
A Single Tuesday in Neuro: LB-102, ATH434, and AbbVie’s $1.4B Bet
Two Phase 2 readouts and a billion-dollar factory landed the same day. Worth reading together.

Two Phase 2 readouts and a billion-dollar factory landed the same day. Worth reading together.